For simplicity, this study adopts a dichotomous model where high TGF-β activity in conjunction with IL-1β and IL-6 is linked to asthma, metabolic dysregulations, and an elevated risk of cancer, while it is inversely associated with the occurrence of AR. This evidence concerns the gene IL6 and cancer.